Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBV-TCR-T (YT-E001) in Nasopharyngeal Carcinoma
NCT03648697Phase 2Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Oct 2018
- Primary completion
- Oct 2021
- Modality
- TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of EBV TCR-T cells in nasopharyngeal carcinoma (NPC), sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
EBV TCR-T cells
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03648697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03648697.